Cargando…
P1709: FERTILITY PRESERVATION FOR YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIAS IN ITALY: A CAMPUS ALL SURVEY.
Autores principales: | Giglio, F., Bruno, A., Dargenio, M., Cerrano, M., Del Principe, M. I., Forghieri, F., Fumagalli, M., Guolo, F., Imovilli, A., Lunghi, M., Mazzone, C., Papayannidis, C., Pasciolla, C., Trappolini, S., Lazzarotto, D., Bonifacio, M., Candoni, A., Ciceri, F., Pizzolo, G., Vitale, A., Foà, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429066/ http://dx.doi.org/10.1097/01.HS9.0000849692.85775.22 |
Ejemplares similares
-
P1708: PREGNANCIES IN YOUNG ADULTS WITH A HISTORY OF ACUTE LYMPHOBLASTIC LEUKEMIA IN ITALY. A CAMPUS ALL SURVEY.
por: Giglio, F., et al.
Publicado: (2022) -
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study
por: Dargenio, Michelina, et al.
Publicado: (2022) -
P372: CMV REACTIVATIONS/INFECTIONS IN PH+ ALL PATIENTS TREATED WITH DASATINIB WITH OR WITHOUT BLINATUMOMAB. A RETROSPECTIVE MULTICENTER CAMPUS ALL STUDY
por: Annunziata, Mario, et al.
Publicado: (2023) -
ACUTE Lymphoblastic Leukemia (ALL) and COVID-19 Infection. a Campus ALL Report
por: Chiaretti, Sabina, et al.
Publicado: (2021) -
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study
por: Fracchiolla, Nicola Stefano, et al.
Publicado: (2023)